The effectiveness of primary PTCA: does patient risk matter?∗∗Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology

Ever since the introduction of primary angioplasty as a method for reperfusion in the setting of acute myocardial infarction in 1982, controversy has surrounded its appropriate use. Taken as a group, modest-sized randomized clinical trials comparing primary angioplasty with thrombolytic therapy in